VYNE
VYNE Therapeutics Inc.
NASDAQHealthcareBiotechnologyUS
USD0.89
+0.08 (+10.51%)
Rating:C+
Company Profile
CEO
David T. Domzalski
IPO Date
2018-01-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$0.78
Prev. Close
$0.81
Day Low
$0.78
Day High
$0.90
52W Low
$0.28
52W High
$1.59
Market Cap
$0.01B
Volume
5.30M